华氏巨球蛋白血症的多组学分析定义两种不同疾病亚型
对MYD88突变华氏巨球蛋白血症患者进行单细胞多组学分析,基于关键谱系定义基因表达识别出记忆B细胞样和浆细胞样两种亚型,二者在分化能力、转录组、染色质可及性和基因组特征上不同,并在批量RNA测序和全基因组测序中验证。
要点
- 基于关键谱系基因表达将MYD88突变华氏巨球蛋白血症分为记忆B细胞样和浆细胞样两亚型。
- 记忆B细胞样亚型不能分化超越记忆B细胞阶段,上调BCR及PI3K/AKT/mTOR信号。
- 浆细胞样亚型可部分分化为浆细胞,NF-κB信号增强且未折叠蛋白反应上调。
核心结论
- 华氏巨球蛋白血症中的可变分化阻滞在临床上表现为两种具有不同表观遗传、突变、转录和临床特征的疾病亚型,对治疗策略有潜在意义。
研究设计与样本
- 对一组MYD88突变华氏巨球蛋白血症患者进行单细胞多组学分析。
- 利用另一组患者的批量RNA测序数据层次聚类验证两亚型的存在与可推广性。
- 通过全基因组测序进一步确立亚型的生物学意义。
主要发现
- 基于关键谱系定义基因表达识别出记忆B细胞样和浆细胞样两种亚型,其完全分化为浆细胞的能力各异。
- 记忆B细胞样亚型不能分化超越记忆B细胞阶段,上调关键记忆B细胞基因、B细胞受体及PI3K/AKT/mTOR信号。
- 浆细胞样亚型可部分分化为浆细胞,上调关键浆细胞基因、NF-κB信号增强且未折叠蛋白反应上调。
- 单细胞RNA测序与单细胞转座酶可及染色质测序联合的拟时序轨迹分析支持各亚型分化能力不同,并提示关键转录因子SPI1、SPIB、BCL11A和XBP1参与。
- 全基因组测序显示CXCR4、NIK和ARID1A突变主要发生于记忆B细胞样亚型,6q缺失发生于浆细胞样亚型。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We carried out a single-cell multiomic analysis on a series of MYD88-mutated Waldenström macroglobulinemia (WM) patients and identified 2 distinct subtypes of disease, memory B-cell (MBC)-like and plasma cell (PC)-like, based on their expression of key lineage defining genes. Biologically, the subtypes are characterized by their variable capacity to differentiate fully toward a PC and exhibit unique transcriptomic, chromatin accessibility, and genomic profiles. The MBC-like subtype is unable to differentiate beyond the MBC stage, upregulates key MBC genes, and is characterized by upregulated B-cell receptor and phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling. In contrast, the PC-like subtype can partially differentiate toward a PC, upregulates key PC genes, has enhanced NF-κB signaling, and has an upregulated unfolded protein response. Pseudotime trajectory analysis of combined single-cell RNA sequencing and single-cell assay for transposase-accessible chromatin with sequencing supports the variable differentiation capacity of each subtype and implicate key transcription factors SPI1, SPIB, BCL11A, and XBP1 in these features. The existence and generalizability of the 2 disease subtypes were validated further using hierarchical clustering of bulk RNA-sequencing data from a secondary set of patients. The biological significance of the subtypes was further established using whole-genome sequencing, in which it was shown that CXCR4, NIK, and ARID1A mutations occur predominantly in the MBC-like subtype, and 6q deletions in the PC-like subtype. We conclude that the variable differentiation blockade seen in WM manifests itself clinically as 2 disease subtypes with distinct epigenetic, mutational, transcriptional, and clinical features, with potential implications for WM treatment strategies.
引用
- Gagler DC, Ghamlouch H, Zhang D, et al. A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes. Blood. 2025. PMID: 40332467. doi:10.1182/blood.2024028164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。